Listen to this articleEstablished in March 2016, IPMC was co-founded by Dr. Robert Hariri, a pioneer and the world’s foremost authority in the field of stem cell technology, and Mr. Young-woo Jang, Chief Executive Officer of IPMC, as the world’s first cell therapy-oriented precision medical services and community complex. IPMC plans to operate corporations based on medical, biotechnology and ICT researchers through collaboration with many global corporations, with IPMC as the core, to promote successful precision medical care business. By fostering the precision medical industry, IPMC will become an international standard and bridgehead for future modern medicine by working with start-ups in genomics, cell medicine, and many other talented global scientists and pharmaceutical companies.
To learn more about IPMChub, see our recent interview with Young-woo Jang, Chief Executive Officer at IPMC:
Q: What will future of medicine look like and where do you place yourself in the industry?
A: Today, the world is at the forefront of the great new trend of the fourth industrial revolution, based on AI (artificial intelligence), the newest and most important turning point in human history. Specifically, our bold challenge can be fused with the major technologies such as Big Data, ACT, AI, and loT (Internet of Things), which are the core technologies of precision medicine, and it can be expanded into various industries such as beauty nutrition, healthcare, and agriculture as well. And the accurate diagnosis using precision medical care can reduce the medical expenses by more than 70%. In the end, this means that we can find the best way to reduce the burden on the national healthcare cost and solve the problem of medical inequality. It will also be a way to anticipate and prevent diseases, and to realize a life that is long, generous, healthy, and comfortable.
As a global platform for precision medicine and personalized industry, IPMC’s business scope includes, but not limited to, (1) clinical application of personalized therapy according to the production and analysis of genomic data (2) implementation of cohort study and data construction for diversification of genetic information by race, sex, and age, (3) stem cell banking (cord blood, placenta and tissue cells), NlPT (Non-invasive prenatal testing), neonatal gene analysis, (4) personalized cell therapy according to the results of analysis of genome data, (5) personalized precision medical examination, and prevention and treatment for welfare of the elderly, and (6) establishment and certification of precision agricultural platform based on standardization of gene inspection and development of production methods.
Q: What’s the vision that guides you?
A: lPMC will be the international business hub, leading the fourth industrial revolution and sharing the long-term vision and insights of precision medicine and personalized industries, and will further grow into a global hub to lead the future medicine. It aims to sublimate its challenge in building the global platform of precision medicine to a BOLD CHALLENGE MOVEMENT. Although the course of the journey may be arduous, IPMC’s mission is essential and monumental that we will continue our bold challenge to learn, innovate and transform the foundations of basic science and clinical practice. To this end, IPMC will
-Play a pioneering role in future standardization of medicine as a representative base of personalized medical industry centered on genome and bio fusion technology services.
-Hold the world’s largest international conference on personalized medicine and preventive medicine, and serve as a global hub of innovation and knowledge.
-Become the global bio service complex IPMC(enter), to realize the world’s first bio-ecosystem, and the starting point of the global smart city IPMC(ity).
Recommended: Document Management Software Docsmore Allows Users To Take Any Document And Make It Fillable Online
Q: What are your plans for 2018?
A: IPMC is starting a bold journey, which will lead the world standing at the most important turning point in human history to the point where genomics and cellular medicine combined with innovative thinking extend and expand the lives of countless citizens around the world. It is launching three major projects in February, 2018, (1) Alzheimer Moonshot as a part of IPMC Senior Health Care, providing a diagnostic platform for early diagnosis and prevention to prevent the spread of population with Alzheimer’s disease which is a representative disease in the aging society. (2) Placell, the amniotic cell therapy product that supports the body’s natural ability to restore tissue to a pre-wound state, and thereby brings protection and support to the wound it covers (3) International Precision Medicine Center Conference (IPMCC), a place to explore and discuss the world’s precision science and personalized industries with citizens and professionals from business, medical, public, research and academia.
Q: What makes IPMC unique and what is the company’s long-term potential?
A: Precision medical field will contribute to the public health by improving the quality of life and reducing the medical expenses through continuous exchange and cooperation with the pharmaceutical and biotechnology industries, and play a key role in the development of the healthcare industry. IPMC is establishing a foundation of precision medical industry and share opinions about precision medical care and future healthcare industry with the world’s top experts in various fields such as medical, biopharmaceuticals, and ACT. IPMC is co-founded by Dr. Robert Hariri, the world’s foremost pioneer and author of stem cell research, and the chairman of Celgene Cellular and co-founder of Human Longevity. The support of world-renowned authorities in the biotechnology field, including Dr. Hariri himself, Mr. John Sculley (the chairman of RxAdvance and Former Apple CEO) and Dr. Andrew C. von Eschenbach (the former Commissioner of the US FDA) prove that our Bold Challenge is meaningful as an odyssey for the commonwealth. Maintaining partnerships with world leading corporations, lPMC possess a strong strategy to share knowledge and information, as well as standardization, in order to effectively integrate related industries and generate synergies.
Q: Why does IPMC emphasize ‘humanity’ and ‘ethics’ rather than merely following technological changes?
A: Improving human beings in a genomic level is quite a scary imagination, but it is not technically impossible with today’s technology and it is possible to change and edit the genes busing stem cells, which would cross the line of humanity. This is why we emphasize that ethics should be the key to maintaining humanity.
IPMC has seen the solutions to these global issues regarding the Fourth Industrial Revolution in the human beings; the solution and the starting point of every issue, and from the environment surrounding humanity. The core of IPMC is humanity; and the core of humanity is ethics. IPMC shall not only lead the area of precision medicine, but will further lead on personalized services industry that is believed to be the core of the great wave of the Fourth Industrial Revolution.
The core value of IPMC is to make humanity live in the most humane way. This will enable the progression of public good in the end. The core of this public good should also be based on ethics that should be restored in the light of humaneness.
As of to date, IPMC Seoul Declaration will make such wishes become reality. For the world, by the all humanity, IPMC wold like to make its first move for the Bold Challenge. I may ask you to Join the Bold!
Activate Social Media:
